Font Size:
a
A
A
Keyword [Faslodex]
Result: 1 - 2 | Page: 1 of 1
1.
Targeting The ER?/Angiopoietin-2/Tie-2 Signaling-mediated Angiogenesis With The FDA-approved Anti-estrogen Faslodex To Increase The Sunitinib Sensitivity In RCC
2.
Estrogen receptor signaling and mechanism of resistance to endocrine therapy
<<First
<Prev Next>
Last>>
Jump to
